JP2023551668A5 - - Google Patents
Info
- Publication number
- JP2023551668A5 JP2023551668A5 JP2023531064A JP2023531064A JP2023551668A5 JP 2023551668 A5 JP2023551668 A5 JP 2023551668A5 JP 2023531064 A JP2023531064 A JP 2023531064A JP 2023531064 A JP2023531064 A JP 2023531064A JP 2023551668 A5 JP2023551668 A5 JP 2023551668A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- approximately
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063117448P | 2020-11-23 | 2020-11-23 | |
| US63/117,448 | 2020-11-23 | ||
| US202063123424P | 2020-12-09 | 2020-12-09 | |
| US63/123,424 | 2020-12-09 | ||
| US202163197160P | 2021-06-04 | 2021-06-04 | |
| US63/197,160 | 2021-06-04 | ||
| US202163261463P | 2021-09-21 | 2021-09-21 | |
| US63/261,463 | 2021-09-21 | ||
| PCT/US2021/060155 WO2022109309A1 (en) | 2020-11-23 | 2021-11-19 | Broadly neutralizing antibodies against influenza neuraminidase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551668A JP2023551668A (ja) | 2023-12-12 |
| JP2023551668A5 true JP2023551668A5 (https=) | 2024-11-08 |
Family
ID=79021106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023531064A Pending JP2023551668A (ja) | 2020-11-23 | 2021-11-19 | インフルエンザのノイラミニダーゼに対する広域中和抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240092876A1 (https=) |
| EP (1) | EP4247495A1 (https=) |
| JP (1) | JP2023551668A (https=) |
| KR (1) | KR20230137293A (https=) |
| AU (1) | AU2021381778A1 (https=) |
| CA (1) | CA3199023A1 (https=) |
| CL (1) | CL2023001462A1 (https=) |
| CO (1) | CO2023007527A2 (https=) |
| IL (1) | IL302963A (https=) |
| MX (1) | MX2023005654A (https=) |
| PH (1) | PH12023551390A1 (https=) |
| TW (1) | TW202229329A (https=) |
| WO (1) | WO2022109309A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025522295A (ja) * | 2022-05-23 | 2025-07-15 | ヒューマブス・バイオメッド・ソシエテ・アノニム | インフルエンザノイラミニダーゼに対する広域中和抗体 |
| AU2023358546A1 (en) * | 2022-10-14 | 2025-05-29 | Longhorn Vaccines And Diagnostics, Llc | Vaccines and antibodies for the treatment and prevention of microbial infections |
| WO2026021428A1 (en) * | 2024-07-23 | 2026-01-29 | Westlake University | Anti-neuraminidase antibodies and uses thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7803C (https=) | ||||
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US7018809B1 (en) | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6833268B1 (en) | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| ES2248127T3 (es) | 1999-10-04 | 2006-03-16 | Medicago Inc. | Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno. |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| AU2004215125B2 (en) | 2003-02-26 | 2011-01-06 | Institute For Research In Biomedicine | Monoclonal antibody production by EBV transformation of B cells |
| ATE492562T1 (de) | 2003-09-24 | 2011-01-15 | Kyowa Hakko Kirin Co Ltd | Rekombinanter antikörper gegen humanen insulin- like growth factor |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| US8119772B2 (en) | 2006-09-29 | 2012-02-21 | California Institute Of Technology | MART-1 T cell receptors |
| US10519251B2 (en) | 2013-12-30 | 2019-12-31 | Epimab Biotherapeutics, Inc. | Fabs-in-tandem immunoglobulin and uses thereof |
| WO2016090170A1 (en) * | 2014-12-05 | 2016-06-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | A potent anti-influenza a neuraminidase subtype n1 antibody |
| EP3294774B1 (en) | 2015-05-13 | 2024-08-28 | Zumutor Biologics, Inc. | Afucosylated protein, cell expressing said protein and associated methods |
| US11254733B2 (en) * | 2017-04-07 | 2022-02-22 | Icahn School Of Medicine At Mount Sinai | Anti-influenza B virus neuraminidase antibodies and uses thereof |
| WO2019024979A1 (en) | 2017-07-31 | 2019-02-07 | Institute For Research In Biomedicine | FUNCTIONAL DOMAIN ANTIBODIES IN THE ELBOW REGION |
| AU2018334886B2 (en) | 2017-09-22 | 2025-06-26 | WuXi Biologics Ireland Limited | Novel bispecific polypeptide complexes |
| CA3096703A1 (en) * | 2018-05-03 | 2019-11-07 | University Of Rochester | Anti-influenza neuraminidase monoclonal antibodies and uses thereof |
-
2021
- 2021-11-19 AU AU2021381778A patent/AU2021381778A1/en not_active Abandoned
- 2021-11-19 EP EP21830556.3A patent/EP4247495A1/en active Pending
- 2021-11-19 US US18/253,385 patent/US20240092876A1/en active Pending
- 2021-11-19 PH PH1/2023/551390A patent/PH12023551390A1/en unknown
- 2021-11-19 TW TW110143246A patent/TW202229329A/zh unknown
- 2021-11-19 MX MX2023005654A patent/MX2023005654A/es unknown
- 2021-11-19 KR KR1020237021242A patent/KR20230137293A/ko active Pending
- 2021-11-19 IL IL302963A patent/IL302963A/en unknown
- 2021-11-19 CA CA3199023A patent/CA3199023A1/en active Pending
- 2021-11-19 WO PCT/US2021/060155 patent/WO2022109309A1/en not_active Ceased
- 2021-11-19 JP JP2023531064A patent/JP2023551668A/ja active Pending
-
2023
- 2023-05-22 CL CL2023001462A patent/CL2023001462A1/es unknown
- 2023-06-07 CO CONC2023/0007527A patent/CO2023007527A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7412521B2 (ja) | Ｃｄ４７に対するヒト化及びキメラモノクローナル抗体 | |
| KR102911478B1 (ko) | 항-tmprss2 항체 및 항원-결합 단편 | |
| JP6711828B2 (ja) | インフルエンザ赤血球凝集素に対するヒト抗体 | |
| AU2016214304B2 (en) | Binding molecules directed against influenza hemagglutinin and uses thereof | |
| JP7664212B2 (ja) | 抗ｃｈｉｋｖ抗体およびその使用 | |
| JP2023551668A5 (https=) | ||
| JP6371222B2 (ja) | インフルエンザの受動免疫用抗体 | |
| TW202233674A (zh) | 用於調節δγ鏈介導之免疫的組成物及方法 | |
| JP2024112879A (ja) | Ｂ型肝炎抗体 | |
| TW201143789A (en) | Antigen binding proteins | |
| CA3199023A1 (en) | Broadly neutralizing antibodies against influenza neuraminidase | |
| CA3199429A1 (en) | Anti-influenza antibodies and combinations thereof | |
| TW202221025A (zh) | 用於治療和預防ｃｏｖｉｄ—１９的ｓａｒｓ—ｃｏｖ—２抗體 | |
| JP2023551666A5 (https=) | ||
| JP2025522295A5 (https=) | ||
| US20240083983A1 (en) | Anti-hemagglutinin antibodies and methods of use thereof | |
| WO2025137632A1 (en) | Antibodies against henipaviruses | |
| KR20260019469A (ko) | 만성 D형 간염의 치료를 위한 항-HBsAg 항체 | |
| EA051498B1 (ru) | АНТИТЕЛА И АНТИГЕНСВЯЗЫВАЮЩИЕ ФРАГМЕНТЫ ПРОТИВ ГЛИКОПРОТЕИНА ШИПОВ SARS-CoV-2 |